PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

Value in Health- United Kingdom

doi 10.1016/j.jval.2012.08.1803

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV


Related search